ZS Associates
 
This week's BioPharma Dive brought to you by
 
 
 
 
 
 
The value of digital transformation in action
 
 
See how life sciences leaders are delivering measurable impact through digital transformation—from smarter trials to global CRMs for intelligence and activation.
 
 
 
 
What’s driving real progress for in silico trials
 
 
The simulation-first era is here. Explore use cases and how AstraZeneca, BMS, Pfizer and Roche are pioneering in silico trials. Reimagine clinical development >>
 
 
 
 
Tech strategy moves for CRM success
 
 
Five considerations for evaluating CRM platforms—from AI integration to cost efficiency and scalable adoption.
Explore the priorities >>
 
 
 
AI, digital twins and data are reshaping drug development
 
 
See where emerging tech is helping pharma rethink evidence, trials and timelines. Learn what’s changing >>
 
 
 

zsinsights@zs.com
© 2025 ZS. All Rights Reserved.
One Rotary Center, 1560 Sherman Avenue, Evanston, Illinois 60201 USA+1 847 492 3600
 
 

Want to reach 108,000+ biopharma executives with your own message? Get the media kit or contact us directly at advertising@industrydive.com.

About this email: You are receiving this message as part of your complimentary newsletter subscription to BioPharma Dive. If you no longer wish to receive the daily newsletter, you can switch to a weekly subscription or unsubscribe. See our full privacy policy. BioPharma Dive is a product of TechTarget, Inc. and its subsidiaries, 275 Grove St. Newton, MA, 02466